Skip to main content
OpenTrials
Completed

NCT Number: NCT06071884

Bridge Device for Surgical Pain for Rotator Cuff Surgery

The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UPMC Outpatient Center

West Mifflin, Pennsylvania, 15236, United States

About this study

The interscalene block is the gold standard for postoperative pain management following rotator cuff surgery. However, the duration of the block does not cover rehabilitation. Therefore, in most cases, patients are discharged from the surgical center with an opioid prescription. There is a growing need to investigate complementary, non-pharmacologic pain-management methods. The Bridge device, which provides auricular neuromodulation of various cutaneous nerves near the ear, is manufactured by Masimo and previously FDA-approved to reduce symptoms of opioid withdrawal. It is a promising technology that could help relieve post-operative pain without exposing patients to the adverse effects of opioids or other pain-relieving medications. The objective of the trial is to investigate the efficacy of the Bridge device in reducing post-operative pain and post-operative opioid consumption in patients undergoing rotator cuff surgery with the typical mode of anesthesia, nerve block plus propofol sedation. Those enrolled will be assigned to a study group and compared to historic cohort (control group). Historic control group involves patients that underwent same surgical procedure performed at the surgical center involved in the study, by the same surgical operator, between 2020 and 2023.

*Prior to study enrollment, the outcome measure timepoints were updated to postoperative days (POD) 1, 3, 5, and 7. This was largely due to pain trajectories in surgical populations often follow a predictable, nonlinear course, with meaningful fluctuations most apparent on alternating days rather than daily increments. By assessing the outcome measures on POD 1, 3, 5, and 7, the revised scheduled timepoints continues to capture initial peak (POD 1), early recovery phase (POD3), the late recovery phase (POD 5), and the resolution/transition phase (POD 7) regarding pain trajectories.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Greater than 18 years of age
  • Willing and able to provide informed consent
  • Scheduled to undergo elective rotator cuff surgery at UPMC
  • No pre-existing medical conditions which would prevent application of the Bridge device on auricle of ear (i.e., skin infection, rash)

Exclusion criteria

  • Opioids dependence
  • Chronic pain condition with daily opioid use
  • Anatomical malformation, which may interfere with placement of the nerve block
  • Raynaud's disease diagnosis
  • Vasculopathy
  • Hemophilia or other coagulopathy, or use of active anticoagulation other than aspirin
  • Patient refusal
  • Pacemaker
  • Pre-existing medical conditions which would prevent application of the Bridge device on auricle of ear (i.e., skin infection, rash)
  • Psoriasis vulgaris

Treatment and study plan

Bridge Percutaneous Nerve Field Stimulator

Device

The Bridge device is an FDA-cleared, drug-free, non-surgical device that uses neuro-modulation to aid in the reduction of symptoms associated with opioid withdrawal through application to branches of the Cranial Nerves V, VII, IX, X, and the occipital nerves. This study is investigating its effectiveness treating post-surgical pain.

Other names: NSS-2 BRIDGE

Primary outcomes

  1. Oral Opioid Use POD 1

    Time frame: Post-Operative Day 1

    This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.

  2. Oral Opioid Use POD 3

    Time frame: Post-Operative Day 3

    This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.

  3. Oral Opioid Use POD 5

    Time frame: Post-Operative Day 5

    This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.

  4. Oral Opioid Use POD 7

    Time frame: Post-Operative Day 7

    This outcome will be measured by total Oral Morphine Equivalents (OME, mg) abstracted from the medical records.

Secondary outcomes

  1. Self-Reported Pain Scores POD 1

    Time frame: Post-Operative Day 1

    Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.

  2. Self-Reported Pain Scores POD 3

    Time frame: Post-Operative Day 3

    Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.

  3. Self-Reported Pain Scores POD 5

    Time frame: Post-Operative Day 5

    Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.

  4. Number of Participants Who Self-Reported Oral Opioid Use POD 5

    Time frame: Post-Operative Day 5

    Collected through the subject diary (response yes/no) and recorded as a count of participants

  5. Number of Participants Who Self-Reported Oral Opioid Use POD 7

    Time frame: Post-Operative Day 7

    Collected through the subject diary (response yes/no) and recorded as a count of participants

  6. Adverse Events Related to Opioid POD 5

    Time frame: Post-Operative Day 5

    Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching

  7. Adverse Events Related to Opioid POD 7

    Time frame: Post-Operative Day 7

    Recorded as yes/no for adverse events related to opioids like nausea, vomiting, dizziness, and itching

  8. Local Adverse Events on Ear Related to Device POD 1

    Time frame: Post-operative Day 1

    Recorded as yes/no for adverse events related to the device such as pain or skin irritation

  9. Local Adverse Events on Ear Related to Device POD 3

    Time frame: Post-operative Day 3

    Recorded as yes/no for adverse events related to the device such as pain or skin irritation

  10. Local Adverse Events on Ear Related to Device POD 5

    Time frame: Post-operative Day 5

    Recorded as yes/no for adverse events related to the device such as pain or skin irritation

  11. Local Adverse Events on Ear Related to Device POD 7

    Time frame: Post-operative Day 7

    Recorded as yes/no for adverse events related to the device such as pain or skin irritation

  12. Self-Reported Pain Scores POD 7

    Time frame: Post-Operative Day 7

    Pain scores will be completed on a Numeric Rating Scale (NRS) of 0=no pain at all and 10=the most severe pain.

Sponsors and collaborators

Lead sponsor

Steven Orebaugh

Other

Collaborators

  • Masimo Corporation

Registry information

Official study title

Evaluation of Bridge Device in Pain Management for Outpatient Rotator Cuff Surgery

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 10, 2023
Registry last updated
Jan 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.